Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in PR+ Advanced/Recurrent Endometrial Cancer
NCT00505739Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2001
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mifepristone in endometrial cancer (EC), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Number of Patients with Overall Response at 2 years. Started Sep 2001; status: completed.
02
Drugs
mifepristone
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00505739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505739.